AAAAAA
Results:
1-14
|
Results: 14
Authors:
Cameron, SB
Nawijn, MC
Kum, WWS
Savelkoul, HFJ
Chow, AW
Citation: Sb. Cameron et al., Regulation of helper T cell responses to staphylococcal superantigens, EUR CYTOKIN, 12(2), 2001, pp. 210-222
Authors:
Winston, DJ
Lazarus, HM
Beveridge, RA
Hathorn, JW
Gucalp, R
Ramphal, R
Chow, AW
Ho, WG
Horn, R
Feld, R
Louie, TJ
Territo, MC
Blumer, JL
Tack, KJ
Citation: Dj. Winston et al., Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients, CLIN INF D, 32(3), 2001, pp. 381-390
Authors:
Kum, WWS
Chow, AW
Citation: Wws. Kum et Aw. Chow, Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1, J INFEC DIS, 183(12), 2001, pp. 1739-1748
Authors:
Kum, WWS
Cameron, SB
Hung, RWY
Kalyan, S
Chow, AW
Citation: Wws. Kum et al., Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells, INFEC IMMUN, 69(12), 2001, pp. 7544-7549
Authors:
Farinas, J
Chow, AW
Wada, HG
Citation: J. Farinas et al., A microfluidic device for measuring cellular membrane potential, ANALYT BIOC, 295(2), 2001, pp. 138-142
Authors:
Chow, AW
Citation: Aw. Chow, Orofacial and odontogenic infections, INFEC DIS S, 2001, pp. 147-162
Authors:
Rubinchik, E
Chow, AW
Citation: E. Rubinchik et Aw. Chow, Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1, VACCINE, 18(21), 2000, pp. 2312-2320
Authors:
Pang, LTY
Ku, WWS
Chow, AW
Citation: Lty. Pang et al., Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody, INFEC IMMUN, 68(6), 2000, pp. 3261-3268
Authors:
Kum, WWS
Laupland, KB
Chow, AW
Citation: Wws. Kum et al., Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenicactivity, and lethality, CAN J MICRO, 46(2), 2000, pp. 171-179
Authors:
Smith, SJ
Lee, AJ
Maddix, DS
Chow, AW
Citation: Sj. Smith et al., Pill-induced esophagitis caused by oral rifampin, ANN PHARMAC, 33(1), 1999, pp. 27-31
Authors:
Epstein, JB
Chow, AW
Citation: Jb. Epstein et Aw. Chow, Oral complications associated with immunosuppression and cancer therapies, INF DIS CL, 13(4), 1999, pp. 901
Authors:
De Beer, ML
Kum, WWS
Pang, LTY
Chow, AW
Citation: Ml. De Beer et al., Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock, MICROB PATH, 27(2), 1999, pp. 61-70
Authors:
Kwok, AYC
Su, SC
Reynolds, RP
Bay, SJ
Av-Gay, Y
Dovichi, NJ
Chow, AW
Citation: Ayc. Kwok et al., Species identification and phylogenetic relationships based on partial HSP60 gene sequences within the genus Staphylococcus, INT J SY B, 49, 1999, pp. 1181-1192
Authors:
De Boer, ML
Kum, WWS
Chow, AW
Citation: Ml. De Boer et al., Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuatedvirulence in a tampon-associated vaginal infection model of toxic shock syndrome, CAN J MICRO, 45(3), 1999, pp. 250-256
Risultati:
1-14
|